Vaccination

Five things you need to know about: mRNA vaccine safety

The world's first mRNA vaccine has begun its rollout after being produced at unprecedented speed as part of the global effort to end the COVID-19 pandemic. A second one is hot on its heels. The two—one made by Pfizer/BioNTech ...

Diseases, Conditions, Syndromes

Why RNA vaccines for COVID-19 raced to the front of the pack

Developing and testing a new vaccine typically takes at least 12 to 18 months. However, just over 10 months after the genetic sequence of the SARS-CoV-2 virus was published, two pharmaceutical companies applied for FDA emergency ...

Vaccination

This is how the new COVID-19 vaccine works

"What is new about this vaccine is that it works using genetic code," says Research Scientist Sven Even Borgos at SINTEF. "This means that the vaccine instructs the body to make small and accurately selected components of ...

Genetics

Treating cystic fibrosis with mRNA therapy or CRISPR

The potential for treating cystic fibrosis (CF) using mRNA therapies or CRISPR gene editing is possible regardless of the causative mutation. CF clinical trials showing that a genotype-agnostic gene therapy for CF is possible ...

Neuroscience

New perspectives to treat neuropsychiatric diseases

Researchers at the Institute of Biology, Eötvös Loránd University (ELTE), Budapest, Hungary, studied the major types of neurons of the prefrontal cortex of the brain in an international collaboration. The research team ...

Diseases, Conditions, Syndromes

Cellular antiviral defenses

Nonsense-mediated mRNA decay (NMD) is a quality control mechanism that regulates levels of both aberrant and wild-type cellular RNAs. It also contributes to antiviral immunity against select plant and human RNA viruses. However, ...

page 25 from 33